I am pleased to announce that Matrix Innovation has achieved great breakthroughs in the last years. We now offer more than 400 different products including resins, scavengers, supported reagents, resins and amino acids.

In accordance with our market expansion plan, we have completed the acquisition of Albatross Chem, a supplier of fine chemicals for the peptide industry. Joining forces with Albatross Chem helps our customers benefit from a wider range of products at even more competitive prices while enhancing our personalized customer service philosophy.

I am also extremely proud to announce that Matrix Innovation signed a licence agreement with PCAS BioMatrix, a division of PCAS (www.pcas.com). Under the terms of this agreement, PCAS BioMatrix acquires the rights to manufacture and commercialize our ChemMatrix® resin, a 100% Polyethylene Glycol polymer developed by our team of researchers.

We focus on continuing to improve the performance of our products as well as our presence on the market. From our head office near Montreal and our production facility in Quebec City, we are working closely with our distributors and collaborators in North America, Europe and Asia, striving together to accomplish our market expansion plan.

I sincerely want to thank each and every one of you for making this journey fulfilling. To all our customers and business partners, we send you our best regards and assure you that we are committed more than ever to making you proud and confident every time you use our products.

André Bilodeau
Chairman of the board